Be part of the knowledge.™

MAO Inhibitors

Media Formats

ReachMD Healthcare Image

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.

Paul Markovitz, MD

Paul Markovitz, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Recommended

Details

Presenters

Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.

Paul Markovitz, MD

Paul Markovitz, MD

Leslie P. Lundt, MD

Leslie P. Lundt, MD

Program Chapters

Segment Chapters

Playlist:

Recommended

FCS and SHTG: Are We Meeting the Need?

IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement

$IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement$

IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement

CME/CE Broadcast Replay

Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference

HF Management for Patients with Comorbid Conditions

Level Up Your Skills: Tailoring Management of HF

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers

FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure